Skip to content
Menu

Mangoceuticals, Inc. MGRX

Full chart Compare
Set alert

Price alert · MGRX

All alert types
0.13 USD -0.01 (-8.74%)

Regular-session close

0.13 -0.01 -5.53%

After hours · Nov 19, 4:00 PM ET

0.1207 Day range 0.156
0.1207 52-week range 1.38
YTD
-81.93%
1 year
-89.22%

 

No chart data for this range yet.
Market cap
2.97M
Revenue (ttm)
866.79K
EPS (ttm)
-0.52
Shares out
2.49M
YTD return
-81.93%
1-year return
-89.22%
Volume
841.88K
Avg volume
655.92K
Open
0.15
Previous close
0.1465
Day's range
0.1207 – 0.156
52-week range
0.1207 – 1.38

Key statistics

50-day average
2.49
200-day average
3.94
Enterprise value
4.40M
Price / sales
7.11
Price / book
4.57
Revenue growth
15.50%
Free cash flow
-2.16M
Total cash
490.24K
Total debt
285.05K
Return on equity
-108.44%
Short % of float
9.99%

Fundamental scorecard

6 of 25 checks passed on MGRX’s reported financials

ValueGrowthProfitabilityHealthDividend

6of 25 checks passed

  • Value 1 of 5
  • Growth 1 of 5
  • Profitability 1 of 5
  • Financial health 3 of 5
  • Dividend 0 of 5

Statements to Sep 30, 2026.

Financials — quick view

All financials
MGRX Revenue — quarterly 69.50K
MGRX Net income — quarterly -3.55M
MGRX EPS — quarterly -0.19

About Mangoceuticals, Inc.

Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com. Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.

Sector
Healthcare
Industry
Health Information Services
Country
United States

News

No recent headlines

Headlines appear here as they are published.

Your note

Sign in to keep a note on MGRX — it syncs with the Stock Master app.

Insider holders

MGRX insider holders
InsiderRelationLatest transactionDateShares held
COHEN JACOB D.Chief Executive OfficerStock GiftAug 25, 20240
D'ALESSIO LORRAINE PAMELADirectorStock Award(Grant)Jun 2, 2024175,000
HAMILTON ALEX PDirectorSaleJun 25, 202450,000
HAMMER AMANDA ELIZABETHChief Operating OfficerStock Award(Grant)Jun 2, 2024175,000
JOHNSTON EUGENE MChief Financial OfficerStock Award(Grant)Oct 2, 2023200,000
MYERS KENNYDirectorStock Award(Grant)Jun 2, 2024175,000

Institution ownership

MGRX institution ownership
Holder% heldSharesValueReported
Ackerman Capital Advisors, LLC2.34%58,224144.40KSep 29, 2024
Captrust Financial Advisors0.69%17,07742.35KSep 29, 2024
Geode Capital Management, LLC0.35%8,75521.71KSep 29, 2024
Peak6 Investments Llc0.24%5,88414.59KSep 29, 2024
McCollum Christoferson Group LLC0.23%5,72014.19KSep 29, 2024
Two Sigma Securities, LLC0.10%2,5236.26KSep 29, 2024

Fund ownership

MGRX fund ownership
Holder% heldSharesValueReported
Fidelity Extended Market Index Fund0.27%6,60316.38KOct 30, 2024
Fidelity Total Market Index Fund0.13%3,2458.05KOct 30, 2024
Fidelity Series Total Market Index Fund0.06%1,5773.91KOct 30, 2024
Fidelity NASDAQ Composite Index Fund0.02%4521.12KOct 30, 2024